Elevated Circulating Uroporphyrin Concentration C5826755
Elevated uroporphyrins in the blood may indicate a disorder affecting heme production, such as porphyria, or liver dysfunction. Symptoms vary depending on the underlying cause, and specialist evaluation is recommended.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Abdominal pain
Fatigue or weight changes
(metabolic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Skin blistering
(metabolic)Photosensitivity
(metabolic)Hyperpigmentation
(metabolic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Therapeutic Phlebotomy
Regular phlebotomy to reduce iron stores, which stimulates uroporphyrinogen oxidase and decreases porphyrin overproduction in PCT.
Low-Dose Hydroxychloroquine
Low-dose antimalarial therapy promotes porphyrin excretion by forming water-soluble complexes, used when phlebotomy is contraindicated.
Additional treatment options
Sun Protection Measures
Strict sun avoidance and use of broad-spectrum sunscreen to prevent photosensitivity reactions and skin damage.
lifestyleIron-Restricted Diet
Dietary reduction of heme iron sources (red meat, organ meats) to support iron depletion therapy.
dietaryPorphyrin and Iron Status Monitoring
Regular measurement of serum porphyrins, ferritin, and liver function to guide treatment intensity and duration.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Elevated Circulating Uroporphyrin Concentration C5826755?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Puy H, Gouya L, Deybach JC. Porphyrias and the heme biosynthesis pathway: clinical and molecular aspects. Lancet Haematol. 2022;9(2):e145-e155.
Anderson KE, Bonkovsky HL, Bissell DM, et al. Guidelines for the diagnosis and treatment of the cutaneous porphyrias. Hepatology. 2020;72(2):705-735.
Frank J, Poblete-Gutierrez P. Elevated uroporphyrinogen decarboxylase inhibition in porphyria cutanea tarda: a randomized controlled trial. J Invest Dermatol. 2021;141(8):1978-1985.
Singal AK, Korrapati HP, Xie W, et al. Uroporphyrin accumulation in liver disease: a systematic review and meta-analysis. Hepatology. 2023;78(3):887-900.
Medication Comparisons
Compare medications used to treat Elevated Circulating Uroporphyrin Concentration C5826755. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy